We are live on ! Find out more
NA

NVP Associates Portfolio holdings

AUM $328M
1-Year Est. Return 166.51%
This Fund
S&P 500
This Quarter Est. Return
+56.12%
1 Year Est. Return
+166.51%
3 Year Est. Return
+953.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$328M
AUM Growth
+$152M
Cap. Flow
+$46.2M
Cap. Flow %
14.08%
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$65.5M
2
SNOW icon
Snowflake
SNOW
+$21.1M
3
ONDS icon
Ondas Inc
ONDS
+$154K

Top Sells

Rank Stock Value
1
BLLN
BillionToOne Inc
BLLN
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 89.83%
2 Technology 8.94%
3 Consumer Staples 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBX
1
MBX Biosciences
MBX
$2.97B
$118M 35.93%
2,136,335
– –
AVLN
2
Avalyn Pharma
AVLN
$1.54B
$74.7M 22.75%
+2,268,404
New +$65.5M
OMDA
3
Omada Health Inc
OMDA
$1.21B
$55.6M 16.93%
2,531,000
– –
ZBIO
4
Zenas BioPharma
ZBIO
$2.11B
$46.7M 14.22%
1,838,482
– –
SNOW icon
5
Snowflake
SNOW
$117B
$29.2M 8.9%
+114,786
New +$21.1M
GROV icon
6
Grove Collaborative
GROV
$43.1M
$4.03M 1.23%
3,225,097
– –
ONDS icon
7
Ondas Inc
ONDS
$4.19B
$129K 0.04%
+15,602
New +$154K
BLLN
8
BillionToOne Inc
BLLN
$4.89B
– –
-513,330
Closed -$40.5M

Similar funds

PC
Pecaut & Co Sioux City, Iowa $328M AUM 21.14% 1-Year Est. Return
KWM
Kaydan Wealth Management Fenton, Michigan $328M AUM 24.93% 1-Year Est. Return
SC
Stance Capital Boston, Massachusetts $328M AUM 48.17% 1-Year Est. Return
VPF
Vantage Point Financial Lisle, Illinois $328M AUM 26.34% 1-Year Est. Return
KA
Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return
DIP
Davis Investment Partners Charlotte, North Carolina $328M AUM 36.73% 1-Year Est. Return
EWA
Encompass Wealth Advisors Portland, Oregon $328M AUM 26.97% 1-Year Est. Return
EAM
EdenTree Asset Management London, United Kingdom $328M AUM 20.4% 1-Year Est. Return

NVP Associates's Q2 2026 Portfolio in Review

As of Q2 2026, NVP Associates held 8 positions worth $328M, up 86% from $176M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

NVP Associates deployed $46.2M of net new capital in Q2 2026, opening 3 new positions. Its largest new stake was Avalyn Pharma: 2,268,404 shares worth $74.7M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 98% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the most notable exit was BillionToOne Inc, an estimated $40.5M sold.

  • NVP Associates's largest Q2 2026 buy was Avalyn Pharma: 2,268,404 shares worth $74.7M.
  • NVP Associates fully exited BillionToOne Inc in Q2 2026, selling an estimated $40.5M.
  • NVP Associates's ten largest holdings make up 100% of its $328M portfolio in Q2 2026.
  • NVP Associates opened 3 new positions and closed 1 in Q2 2026.
  • NVP Associates's portfolio value rose 86% quarter-over-quarter to $328M.

Based on NVP Associates's 13F filing for Q2 2026, filed 7 Aug 2026.